Biophytis S.A. (BPTSY)
OTCMKTS · Delayed Price · Currency is USD
2.000
0.00 (0.00%)
Oct 23, 2025, 8:00 PM EDT
Biophytis Market Cap
Biophytis has a market cap or net worth of $3.48 million as of October 24, 2025. Its market cap has increased by 75.14% in one year.
Market Cap
3.48M
Enterprise Value
14.80M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.00
Market Cap Chart
Since July 13, 2015, Biophytis's market cap has decreased from 49.80M to 3.48M, a decrease of -93.00%. That is a compound annual growth rate of -22.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 3.48M | 20.87% |
| Dec 31, 2024 | 2.88M | -28.25% |
| Dec 29, 2023 | 4.02M | -50.09% |
| Dec 30, 2022 | 8.05M | -88.62% |
| Dec 31, 2021 | 70.76M | -37.02% |
| Dec 31, 2020 | 112.35M | 3,661.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |